European Commission Directorate-General for International Partnerships (EuropeAid HQ)

Antimicrobial Resistance Surveillance in Malta: Integrating Whole Genome Sequencing for the molecular characterisation of clinically isolated carbapenem / colistin resistance Enterobacteriaceace: AMR-MT-WGS

Last update: Aug 9, 2023 Last update: Aug 9, 2023

Details

Locations:Malta
Start Date:Jul 1, 2023
End Date:Jun 30, 2025
Sectors:Health, Laboratory & Measurement
Health, Laboratory & Measurement
Categories:Grants
Date posted:Aug 9, 2023

Associated funding

Associated experts

Description

Programme(s): EU4Health Programme (EU4H)

Topic(s): EU4H-2022-DGA-MS-IBA-01-02

Type of action: EU4H Project Grants

Project ID: 101112890

Objective:

The increase in prevalence of antimicrobial resistance (AMR) is considered as a major threat to public health globally. The majority of AMR surveillance is currently being undertaken by the use, of common available microbiology methods and phenotypic drug susceptibility testing. The addition of molecular methods such as whole genome sequencing (WGS), can provide a better understanding of the mechanisms of resistance and the relatedness of strains. Gram-negative bacteria display the broadest range of resistance, of these carbapenem-resistance Enterobacteriaceae (CRE) are becoming a leading public health concern. Moreover, due to the lack of accessible treatment, some CRE isolates were found to carry mobile colistin-resistant genes (mcr). In this project WGS will be implemented / integrated within the established AMR surveillance in Malta, to molecular characterize carbapenem / colistin resistant Enterobacteriaceae.

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.